Form4insider filings, from the source

SEC Form 4 · accession 0000902664-17-002616

PUMA BIOTECHNOLOGY, INC. · PBYI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Phillip Gross
10% Owner
Period of report
Jun 8, 2017
Accepted (ET)
Jun 12, 2017 · 6:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401667

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.0001 ("Common Stock")F1,F2Jun 8, 2017S89,538$80.8821D3,854,302ISee footnote
Common StockF3,F2Jun 8, 2017S10,462$81.4938D3,843,840ISee footnote
Common StockF4,F2Jun 9, 2017S34,206$80.4114D3,809,634ISee footnote
Common StockF5,F2Jun 9, 2017S24,110$81.289D3,785,524ISee footnote
Common StockF6,F2Jun 12, 2017S77,247$79.1893D3,708,277ISee footnote
Common StockF7,F2Jun 12, 2017S11,697$80.0833D3,696,580ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses